• Home
  • About
    • About Panaxea
    • Meet our team
    • Careers
  • Services
    • Health Technology Assessment
    • Health Services & Systems Research
    • Health Innovation Assessment Consultancy
  • News & Cases
  • Publications
  • Contact
  • Privacy Statement Panaxea
Health Economic Modeling

Antibiotics are a limited resource. At the current pace of injudicious use, all antibiotics will soon become ineffective. Panaxea together with Thermo Fisher developed a health-economic model for the use of Procalcitonin (PCT) to determine whether PCT can cost-effectively reduce the use of antibiotics for sepsis. This brochure displays among other things the health economic model results of PCT’s cost-effectiveness.

Panaxea b.v. supports decision making in healthcare by assessing the relative advantage of healthcare innovations. Our clients include patients, health and life science innovators and investors, health technology adopters, public and private payers, and policymakers.

Follow us on Twitter

Tweets by @PANAXEA

Useful Links

Home
About Panaxea
Services
Publications
Contact Us

Social Media

 Twitter Linkedin

Contact Information

PANAXEA b.v.
Matrix II, unit 1.10
Science Park 400
1098 XH Amsterdam
The Netherlands

+31 20 7400 778
www.panaxea.eu
info@panaxea.eu

© 2019 Panaxea. All Rights Reserved.
  • Privacy Statement Panaxea